De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Clinical trial NCT00328770 · COMPLETED

Trial details

NCT number: NCT00328770
Sponsor: University of Alberta
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Liver Carcinoma

Start date: 1996-12-01
Primary completion: 2006-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.